For nearly 20 years, eGFR equations have helped clinicians screen for kidney disease and care for patients. But the problems of racial classification related to eGFR have not been closely examined, write authors Nwamaka D. Eneanya, MD, MPH; Wei (Peter) Yang, PhD; and Peter P. Reese, MD, MSCE.